Skip to main content
TipRanks
Go Ultimate75% OFF

BioGend Therapeutics Co., Ltd. (6733) Balance Sheet

BioGend Therapeutics Co., Ltd. Balance Sheet

BioGend Therapeutics Co., Ltd.'s total assets for Q2 2026 were NT$1.13B, a decrease of 2.12% from the previous quarter. TW:6733 total liabilities were NT$45.70M for the fiscal quarter, a 3.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 815.38MNT$ 912.70MNT$ 1.05BNT$ 821.82MNT$ 1.02B
NT$ 57.74MNT$ 66.19MNT$ 93.71MNT$ 90.56MNT$ 80.42M
NT$ 757.64MNT$ 846.51MNT$ 956.77MNT$ 731.27MNT$ 943.45M

Currency in TWD

BioGend Therapeutics Co., Ltd. Liabilities to Assets

0400M800M1.2B0 %4 %8 %12 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets